Evidence underpinning the choice of anti-hypertensive therapy in pregnancy is inadequate to make firm recommendations. There are no reports of serious effects with methyl-dopa following long and extensive use. Calcium antagonists, labetalol and hydralazine are commonly used, particularly for resistant hypertension in the third trimester. However, angiotensin-converting enzyme (ACE)-inhibitors should be avoided because they may cause oligohydramnios, renal failure and intra-uterine death.
A.
Hydralazine
B.
Labetalol
C.
Lisinopril
D.
Methyl-dopa
E.
Nifedipine.
Your Answer was: C
Correct Answer: C
Comment
No comments:
Post a Comment